Time Aktie
WKN DE: A11312 / ISIN: US8872281048
|
19.12.2025 16:59:04
|
This Cytokinetics Director Sold 5,000 Shares in November. Is It Time to Dump the Biopharmaceutical Stock?
B. Lynne Parshall, Director at Cytokinetics, Incorporated (NASDAQ:CYTK), reported the sale of 5,000 shares in an open-market transaction valued at ~$323,650 on November 19, 2025; direct ownership following the sale stands at 22,933 shares, according to the SEC Form 4 filing.Transaction value based on SEC Form 4 reported price ($64.73); post-transaction value based on Nov. 19, 2025 market close ($64.79).Note: 1-year performance calculated using November 19th, 2025 as the reference date.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!